Z
Zoya Poltorak
Researcher at Technion – Israel Institute of Technology
Publications - 7
Citations - 4403
Zoya Poltorak is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Vascular endothelial growth factor & Vascular endothelial growth factor C. The author has an hindex of 5, co-authored 7 publications receiving 4294 citations.
Papers
More filters
Journal ArticleDOI
Vascular endothelial growth factor (VEGF) and its receptors
TL;DR: Recent developments that have widened considerably the understanding of the mechanisms that control V EGF production and VEGF signal transduction are focused on and recent studies that have shed light on the mechanisms by which VEGf regulates angiogenesis are reviewed.
Journal ArticleDOI
VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix
Zoya Poltorak,Tzafra Cohen,Revital Sivan,Yelena Kandelis,Gadi Spira,Israel Vlodavsky,Eli Keshet,Gera Neufeld +7 more
TL;DR: Recombinant VEGF145 induced the proliferation of vascular endothelial cells and promoted angiogenesis in vivo and seems to possess a unique combination of biological properties distinct from those of previously characterized V EGF species.
Journal ArticleDOI
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants.
Gera Neufeld,Tzafra Cohen,Hela Gitay-Goren,Zoya Poltorak,Shoshana Tessler,Rivka Sharon,Stella Gengrinovitch,Ben-Zion Levi +7 more
Journal ArticleDOI
The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases.
TL;DR: Evidence is found indicating the neuropilins form complexes with another VEGF receptor, VEGFR-1, however, the biological function of this complex remains to be elucidated.
Patent
Angiogenic factor and use thereof in treating cardiovascular disease
TL;DR: In this article, a novel VEGF protein product and nucleic acid encoding the novel protein product, comprising exons 1-6 and 8 of the VEGGF gene, and its use thereof in treating the cardiovascular system and its diseases through effects on anatomy, conduit function, and permeability.